4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000950170-25-110163
10% owner sold 260,713 shares at an average $39.34 ($10,255,244)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. 10% owner | 2025-08-15 | Sale | −145,051 | $39.50 | $5,729,515 | 1,430,848 | D: show line 1 in the form |
| Versant Venture Capital VI, L.P. 10% owner | 2025-08-15 | Sale | −69,949 | $39.50 | $2,762,986 | 977,963 | I: show line 2 in the form |
| Versant Venture Capital VI, L.P. 10% owner | 2025-08-18 | Sale | −30,628 | $38.56 | $1,181,049 | 1,400,220 | D: show line 3 in the form |
| Versant Venture Capital VI, L.P. 10% owner | 2025-08-18 | Sale | −15,085 | $38.56 | $581,694 | 962,878 | I: show line 4 in the form |
| Open-market sales · 260,713 sh · avg $39.34 · $10,255,244 | |||||||
Loading xslF345X05/ownership.xml…